Precision Nutrition Market - Global Forecast 2025-2030

Senior executives in healthcare, food, and life sciences are rapidly integrating precision nutrition into corporate strategy. This report delivers clear analysis and actionable insights, empowering your organization to adapt strategies and investments for the shifting health personalization landscape.

Market Snapshot: Precision Nutrition Market Size and Growth

The precision nutrition market is experiencing solid growth, expanding from USD 6.33 billion in 2024 to USD 6.77 billion in 2025, with expected continued momentum to reach USD 9.59 billion by 2030 at a CAGR of 7.16%. This trajectory reflects increasing business adoption, ongoing regulatory adaptation, and the convergence of genomics, digital platforms, and validated interventions across global healthcare and consumer sectors.

Scope & Segmentation

This study provides a detailed analysis of the precision nutrition ecosystem. The segmentation covers critical market facets and highlights key areas for strategic planning and investment:

• Offering: Digital platforms, functional foods and beverages, precision meal kits, postbiotics, prebiotics, probiotics, synbiotics, blood biomarker test kits, breath analyzers, metabolomics/proteomics test kits, microbiome test kits, nutrigenetic DNA test kits, continuous glucose monitors, heart rate monitors, HRV monitors, and sleep trackers.
• Technology: Genomics, metabolomics, microbiome analysis, proteomics, transcriptomics.
• Application: Chronic disease management (including cardiovascular, diabetes, hypertension, metabolic liver disease, obesity), dermatology, digestive and gut health (IBD, IBS, SIBO), immune support, cognitive health, oncology support, preventive wellness, and sports performance.
• Sales Channel: Pharmacies, specialty stores, supermarkets, hypermarkets, brand websites, e-commerce platforms.
• End User: Biopharma companies, contract research organizations, fitness and sports organizations, food and beverage firms, healthcare providers, individual consumers, research and academia.
• Geography: Americas (including North America and Latin America), Europe, Middle East and Africa, and Asia-Pacific regions with country-level detail across major and emerging markets.

Market Leaders & Innovators

• Abbott Laboratories, Archer Daniels Midland Company, BASF SE, Bayer AG, Cargill, Danone S.A., DSM-Firmenich AG, Elysium Health, GenoPalate Inc, Nestlé S.A., Novonesis Group, Nuritas Ltd., Nutrigenomix Inc., Perfect Day, Precision Nutrition Inc., Prenetics Global Limited, Viome Life Sciences, GENESIS Health and Lifestyle Solutions, AMILI Pte Ltd, Ajinomoto Co., Xcode Life, Sun Genomics, REVIV Global, Fagron Genomics, Care4Agro, Trouw Nutrition by Nutreco, ZOE Limited, Amway Corporation.

Key Takeaways for Strategic Decision-Makers

• Integrated personalization is emerging as a priority at the board level, driven by convergence across genomics, microbiome analysis, and biosensor technologies.
• Commercial success now depends on robust validation frameworks, interoperability, and scalable digital and offline delivery models.
• New regulatory protocols require early, proactive engagement and investment in clinical validation and quality systems to accelerate market access.
• Cross-industry partnerships are vital for unlocking new value chains—spanning functional foods, supplements, clinical services, and digital platforms.
• Segmentation intelligence supports targeted R&D investments, adaptive business models, and region-specific go-to-market strategies that reflect end user needs, from healthcare providers to consumers.
• Regional differences in regulatory requirements and consumer demand play a pivotal role in shaping piloting locations, manufacturing, and product localization strategies.

Tariff Impact on the Precision Nutrition Market

Recent United States tariff adjustments have created additional layers of complexity for ingredient sourcing, manufacturing, and the import of diagnostic components essential for clinical and consumer testing. Organizations are reassessing supplier diversification, nearshoring, and vertical integration to strengthen supply chain resilience and minimize operational disruptions. The shift drives closer collaboration among commercial, legal, and supply chain teams to navigate customs and regulatory compliance challenges.

Methodology & Data Sources

This analysis uses a multi-method approach, including structured primary interviews with clinical, laboratory, product, supply chain, and regulatory leaders. Secondary sources include peer-reviewed publications, regulatory guidance, and company disclosures. Expert adjudication ensures reliability, and scenario-based validation is used to verify claims and assess supply chain sensitivity.

Why This Report Matters

• Enables executive teams to anticipate market shifts and invest in scalable, evidence-driven product and service portfolios.
• Supports operational resilience by revealing the impact of new tariffs on sourcing and innovation flow.
• Provides segmentation and regional intelligence required to tailor strategies for business units, regulatory environments, and key customer segments.

Conclusion

This report equips senior leaders with data-driven insights to confidently advance precision nutrition strategies. Actionable recommendations prepare organizations to align science, operations, and commercial activities for measurable impact and sustainable growth.